ConcertAI

Attending the Pharma and MedTech Services Investment Summit tomorrow in San Francisco, CA? Join us at 3:00pm PT where Seungtaek Lee, Vice President of Strategic Provider Partners at ConcertAI, will be part of an illuminating panel discussion titled Clinical Research Technology. Featured panelist from: Topography Health, Jefferies, ConcertAI, Genstar Capital, Norwest Venture Partners, and McDermott Will & Emery Don't miss this opportunity to hear from industry experts and gain valuable insights into the pharma and medtech sectors. Learn more: https://hubs.ly/Q02vNThd0 #Pharma #MedTech #InvestmentSummit #PanelDiscussion #IndustryExperts

Today is the last day of exhibits at Asembia 2024! There is still time to come by the ConcertAI booth, #1518 to learn more about innovations in commercial data management. Here’s what Faith DeFreitas, Director, Business Intelligence Technology, is excited to showcase at Asembia: “ConcertAI’s comprehensive suite of web-based applications is tailored for pharmaceutical companies with specialty products and provides insights into key commercial performance metrics about the patient journey and brand performance. Our solutions utilize integrated data sets to explore metrics inside and outside the SP and Hub network, which illuminate the entire patient experience. Speak with us to learn more about how we empower field teams with predictive analytics and real-time alerts to proactively address patient onboarding challenges and streamline workflows of patient support program teams with our copilot solution." #Asembia2024 #PatientAnalytics #CommercialSystems #DataAggregation

We are having a great time at Asembia 2024! There’s still time to come by the ConcertAI booth to learn more about our innovations in commercial data management and specialty data aggregation. Ned Bement Bement, VP, Sales says “There has never been a better time to leverage integrated data sets, predictive models and AI applications to drive patient access and outcomes.” Join us in booth #1518 for an insightful conversation! Schedule a meeting with our team: https://hubs.ly/Q02vCTZc0 #Asembia2024 #PatientAnalytics #CommercialSystems #DataAggregation

"As a member of the Commercial Solutions team at ConcertAI, I lead commercial analytics, insights, and consulting efforts, utilizing our data and technology assets to deliver deep, strategic, and actionable insights to your customers. By leveraging the value of multiple datasets, including claims, specialty pharmacy, HUB, copay and more our team generates insights across patient, payer and HCP domains. Commercial solutions at ConcertAI is uniquely equipped to provide value from data aggregation, to data governance, and leveraging that data via analytics and next generation AI solutions. Looking forward to meeting you at Asembia!" - Chirag Shah, Senior Manager, Business Analytics. Learn more at Asembia in booth #1518! Or, schedule a meeting with our team: https://hubs.ly/Q02vyLHZ0 #Asembia2024 #PatientAnalytics #CommercialSystems #DataAggregation

Check out this clip from Drug Discovery & Development where Jeff Elton, CEO of ConcertAI, shares his insights on the current state of AI adoption in life sciences. #LifeSciences #Technology #Innovation #healthcare

Exhibits at Asembia are now open! Stop by booth #1518 to see how ConcertAI is providing specialty data aggregation, integration, and reporting systems. Yash Shah, Sr. Director, Strategy at ConcertAI, puts it best: “There has never been a better time to leverage integrated data sets, predictive models, and AI applications to drive patient access and outcomes. Join us for an insightful conversation at Asembia this year.” Schedule a meeting with our team: https://hubs.ly/Q02vkCT-0 #Asembia2024 #PatientAnalytics #InnovateWithData #DataAggregation #ReportingSystems

Asembia exhibits kick off today and we can't wait to reconnect, and forge new connections. Be sure to visit booth #1518 or schedule a meeting with our team: https://hubs.ly/Q02vkmSK0 Here’s what Michael Bassett, Technical Director, Advanced Analytics is excited to showcase: “At Asembia 2024, ConcertAI's Commercial Solutions team is showcasing our unique capabilities to break down data silos and supercharge insights with fully integrated patient data, deliver the right insight to the right brand at the right time without reliance on a single data vendor, and leverage cutting-edge technologies and expert insights to understand and address individual barriers to treatment. We believe that patients are more than their disease, and our patient analytics reflect the evidence we are missing from the real world.” #Asembia2024 #ConcertAI #PatientAnalytics #InnovateWithData #BreakDownDataSilos #EmpowerPatients

Join us at ISPOR 2024 on May 8 for a poster session featuring a presentation by Lilly on the: "Budget Impact of Pirtobrutinib for Patients With Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) in the United States (US)” presented by Eli Lilly and Company. The presentation will focus on the objectives of Pirtobrutinib, a non-covalent (reversible) BTK inhibitor with FDA approval for patients with MCL and CLL/SLL. The budget impact model developed by Lilly estimates the impact of introducing pirtobrutinib as a treatment option for these patients in the US. The results showed minimal budget impact for patients with MCL or CLL/SLL, largely due to the small patient populations eligible for treatment. Learn more: https://hubs.ly/Q02vcD180 #ISPOR2024 #BudgetImpact #Pirtobrutinib #HealthcareResearch #EconomicEvaluation

Join the poster session at ISPOR 2024 on May 6 titled: " Comparative Analysis of Different Methods of Disease Progression Data Capture in Patients With Metastatic Castration-Resistant Prostate Cancer" presented by Novartis. This paper compared different methods of capturing disease progression data in 3,855 mCRPC patients to determine the value of progressions not linked to treatment changes. Using ConcertAI data, they found that linking progression to treatment changes improved model fit and correlation values. This analysis suggests that capturing progressions not connected to treatment changes may not provide additional benefit when modeling the relationship between progression and mortality in mCRPC. Learn more at ISPOR 2024: https://hubs.ly/Q02vcBsh0 #ProstateCancerResearch #ISPOR2024 #Novartis #Publication

This month is Esophageal Cancer Awareness Month. We are standing together in the fight against this disease. We stand in solidarity with patients who are bravely battling esophageal cancer, as well as with our fellow oncology professionals who are working tirelessly towards finding a cure. Together, we can make a difference. At ConcertAI, we are committed to providing on-demand access to the largest and most sophisticated oncology data for accelerated Real World Evidence (RWE) and improved patient outcomes. Learn more: https://hubs.ly/Q02v1d9c0. #EsophagealCancerAwareness #RealWorldEvidence #PatientOutcomes #StandTogether